Browse drugs

… trial is designed to confirm whether adjunctive intra-arterial alteplase, administered after successful MT, improves clinical outcomes i…

…, and functional dependency (28.1% vs 22.8%, p=0.37).Conclusion TNK and tPA demonstrated comparable safety and mortality in BAO tre…

…Background Tenecteplase (TNK) has emerged as an alternative to alteplase for acute isch…

…ytic therapy with its single bolus administration compared with alteplase. Moreover, its high specificity for fibrin may contribute to a …

…label aspirin for days 2–7. Both groups will receive open-label aspirin (100 mg daily) for days 8–90.Study outcomes The primary efficac…

…us thrombolytics are the only accessible reperfusion treatment. Tenecteplase is established as the preferred thrombolytic for selected patie…

… to large vessel occlusion. Intravenous thrombolysis (IVT) with alteplase remains the first-line therapy within the approved time window,…

…patient presented with left-sided weakness and was treated with alteplase, after which he experienced left arm ischaemia. Imaging reveale…

…y, or bacterial growth). All received drainage ± fibrinolytics (Alteplase 10 mg + DNase 5 mg daily for up to 3 days). Group 1 (pre-Nov. 2…

…he probable embolic sources. The patient was then discharged on apixaban for atrial fibrillation, and referred to the neurosurgeons for …